|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nielsen DL, Palshof JA, Larsen FO, Jensen
BV and Pfeiffer P: A systematic review of salvage therapy to
patients with metastatic colorectal cancer previously treated with
fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.
Cancer Treat Rev. 40:701–715. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Augestad KM, Bakaki PM, Rose J, Crawshaw
BP, Lindsetmo RO, Dørum LM, Koroukian SM and Delaney CP: Metastatic
spread pattern after curative colorectal cancer surgery. A
retrospective, longitudinal analysis. Cancer Epidemiol. 39:734–744.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun C, Deng Y, Zhou H and Hu ZQ: Risk
factors for the development of metachronous bone metastasis in
colorectal cancer patients after curative resection. Int J Surg.
21:145–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kyle RA and Rajkumar SV: Multiple myeloma.
N Engl J Med. 351:1860–1873. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alzrigat M, Párraga AA and
Jernberg-Wiklund H: Epigenetics in multiple myeloma: From
mechanisms to therapy. Semin Cancer Biol. 51:101–115. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Durie BG, Harousseau JL, Miguel JS, Bladé
J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J,
Sonneveld P, et al: International uniform response criteria for
multiple myeloma. Leukemia. 20:1467–1473. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kyle RA and Rajkumar SV: Criteria for
diagnosis, staging, risk stratification and response assessment of
multiple myeloma. Leukemia. 23:3–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou
X, Wang Z, Fang Y, Pan H and Han W: Multiple primary malignant
tumors-a clinical analysis of 15,321 patients with malignancies at
a single center in China. J Cancer. 9:2795–2801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
San Miguel JF, Gutiérrez NC, Mateo G and
Orfao A: Conventional diagnostics in multiple myeloma. Eur J
Cancer. 42:1510–1519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katzel JA, Hari P and Vesole DH: Multiple
myeloma: Charging toward a bright future. CA Cancer J Clin.
57:301–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li QL, Ma JA, Li HP, Huang RB, Hu CH, Liu
XL, Gao YW, Feng GH and Wu F: Synchronous colorectal cancer and
multiple myeloma with chest wall involvement: Is this a
coincidence? Curr Probl Cancer. 41:413–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kou CJ, Romain J, Broadwater DR and
Barnett T: Colorectal cancer in a patient with multiple myeloma: A
treatment Dilemma. Cureus. 12:e121122020.PubMed/NCBI
|
|
14
|
Palumbo A and Anderson K: Multiple
myeloma. N Engl J Med. 364:1046–1060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
von Moos R, Costa L, Gonzalez-Suarez E,
Terpos E, Niepel D and Body JJ: Management of bone health in solid
tumours: From bisphosphonates to a monoclonal antibody. Cancer
Treat Rev. 76:57–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christensen TD, Jensen SG, Larsen FO and
Nielsen DL: Systematic review: Incidence, risk factors, survival
and treatment of bone metastases from colorectal cancer. J Bone
Oncol. 13:97–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhenghong and Zihua Z: Guoweijian,
Zhangning, Caiyunyun, Yingjiangshan and Xiaomi: Retrospective study
of predictors of bone metastasis in colorectal cancer patients. J
Bone Oncol. 9:25–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sundermeyer ML, Meropol NJ, Rogatko A,
Wang H and Cohen SJ: Changing patterns of bone and brain metastases
in patients with colorectal cancer. Clin Colorectal Cancer.
5:108–113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Santini D, Tampellini M, Vincenzi B,
Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C,
Calipari N, et al: Natural history of bone metastasis in colorectal
cancer: Final results of a large Italian bone metastases study. Ann
Oncol. 23:2072–2077. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Coleman RE, Croucher PI, Padhani AR,
Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R and
Costa L: Bone metastases. Nat Rev Dis Primers. 6:832020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
von Eyben FE and Kairemo K: Meta-analysis
of (11)C-choline and (18)F-choline PET/CT for management of
patients with prostate cancer. Nucl Med Commun. 35:221–230. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wondergem M, van der Zant FM, van der
Ploeg T and Knol RJ: A literature review of 18F-fluoride PET/CT and
18F-choline or 11C-choline PET/CT for detection of bone metastases
in patients with prostate cancer. Nucl Med Commun. 34:935–945.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Connelly TM, Piggott RP, Waldron RM and
O'Grady P: Unusual osseous metastases from rectal adenocarcinoma: A
case report and review of the literature. J Gastrointest Surg.
19:1177–1186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanthan R, Loewy J and Kanthan SC:
Skeletal metastases in colorectal carcinomas: A Saskatchewan
profile. Dis Colon Rectum. 42:1592–1597. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:6243s–6249s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawamura H, Yamaguchi T, Yano Y, Hozumi T,
Takaki Y, Matsumoto H, Nakano D and Takahashi K: Characteristics
and prognostic factors of bone metastasis in patients with
colorectal cancer. Dis Colon Rectum. 61:673–678. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Assi R, Mukherji D, Haydar A, Saroufim M,
Temraz S and Shamseddine A: Metastatic colorectal cancer presenting
with bone marrow metastasis: A case series and review of
literature. J Gastrointest Oncol. 7:284–297. 2016.PubMed/NCBI
|
|
29
|
Ma CX, Guan X, Wei R, Wang S, Quan JC,
Zhao ZX, Chen HP, Liu Z, Jiang Z and Wang XS: The distinction of
clinicopathological characteristics, treatment strategy and outcome
in colorectal cancer patients with synchronous vs. Metachronous
bone metastasis. Front Oncol. 10:9742020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cowan AJ, Green DJ, Kwok M, Lee S, Coffey
DG, Holmberg LA, Tuazon S, Gopal AK and Libby EN: Diagnosis and
management of multiple myeloma: A review. JAMA. 327:464–477. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh H, Sethi S, Raber M and Petersen LA:
Errors in cancer diagnosis: Current understanding and future
directions. J Clin Oncol. 25:5009–5018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Phillips RL Jr, Bartholomew LA, Dovey SM,
Fryer GE Jr, Miyoshi TJ and Green LA: Learning from malpractice
claims about negligent, adverse events in primary care in the
United States. Qual Saf Health Care. 13:121–126. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raab SS and Grzybicki DM: Quality in
cancer diagnosis. CA Cancer J Clin. 60:139–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh H, Arora HS, Vij MS, Rao R, Khan MM
and Petersen LA: Communication outcomes of critical imaging results
in a computerized notification system. J Am Med Inform Assoc.
14:459–466. 2007. View Article : Google Scholar : PubMed/NCBI
|
